銘普光磁(002902.SZ)向飛速創新提供400GSR8光纖模塊 協議總金額預計3000萬元
格隆匯12月17日丨銘普光磁(002902.SZ)宣佈,公司與深圳市飛速創新技術股份有限公司(簡稱“飛速創新”)於2020年12月15日簽訂了《關於<採購框架協議>之補充協議》,公司向飛速創新提供400GSR8光纖模塊,協議總金額預計為3000萬元。
公司與飛速創新前身“深圳市宇軒網絡技術有限公司”於2019年11月21日,針對“光模塊10G-100G產品”簽訂了《戰略合作協議》、針對“光模塊400G產品”簽訂了《合作開發協議》;於2020年1月1日,針對“光纖模塊、高速線纜等產品和/或服務”簽訂了《採購框架合同》,在此基礎上籤訂了該補充協議,雙方形成了良好的戰略合作伙伴關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.